US$ 23.11
oral semaglutide brand name Tablets Ozempic (semaglutide): Uses, Side Effects,
Description
The diabetes NDA was submitted in October 2021 and approved under priority review.) Medical Disclaimer This article is for educational and informational purposes only
Once the vial is opened, new guidelines come into play
We build platforms that understand the specific biological timeline of therapy

Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report Top 10 OZEM HoldingsNovo Nordisk A/S (NYSE:NVO)Holding Weight: 12.85%Eli Lilly and Company (NYSE:LLY)Holding Weight: 12.51%Pfizer (NYSE:PFE)Holding Weight: 6.25%Viking Therapeutics (NASDAQ:VKTX)Holding Weight: 6.01%CSPC Pharmaceutical Group LimitedHolding Weight: 5.80%Kailera Therapeutics (NASDAQ:KLRA)Holding Weight: 5.76%Chugai Pharmaceutical Co LtdHolding Weight: 4.27%Ascletis Pharma Inc.Holding Weight: 4.17%Zealand Pharma A/SHolding Weight: 3.79%Amgen (NASDAQ:AMGN)Holding Weight: 3.75%Full Holdings DetailsOZEM Sector ExposureOZEM Industry Exposure This page (NASDAQ:OZEM) was last updated on 7/18/2026 by MarketBeat.com Staff

Anti-obesity medicines without a doubt have revolutionized this landscape for sustainable weight loss, Anegawa said in an interview with Bloomberg Radio

Horvei, L
